Загрузка...
In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.
In vitro activity of LB20304 against 1,231 clinical isolates was evaluated and compared with those of ciprofloxacin, sparfloxacin, lomefloxacin, and ofloxacin. LB20304 demonstrated the most potent activity against gram-positive bacteria. It was 32- to 64-fold more active than ciprofloxacin against m...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1996
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC163372/ https://ncbi.nlm.nih.gov/pubmed/8726042 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|